Basel, Switzerland

Georg Anner

This inventor holds 6 USPTO granted patents. Top assignee: Ciba-Geigy Corporation. Active years: 1977-1986.


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 1977-1986

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Georg Anner: Innovator in Pharmaceutical Chemistry

Introduction

Georg Anner is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel steroid compounds. With a total of 6 patents, Anner's work has had a considerable impact on the medical industry.

Latest Patents

Among his latest patents, Anner has developed polyhalogeno-steroids, specifically novel 6.alpha.,9.alpha.,21-trihalogeno-11.beta.-hydroxy-16.alpha. or 16.beta.-methyl-17.alpha.-propionyloxy-pregn-4-ene-3,20-dione compounds. These compounds are characterized by their unique formula, where X represents chlorine or fluorine, and R can be various groups such as --CH.sub.2 CH--, --CH.dbd.CH--, or --CH.dbd.CCl--. The chlorine atom is positioned at 2 in the steroid numbering, and the 16-methyl radical can be either .alpha.- or .beta.-oriented. These compounds are particularly useful as pharmaceuticals, especially as anti-inflammatory agents for topical administration. Another significant patent involves a process for the manufacture of steroid carboxylic acid lactones. This advantageous method includes a series of reactions starting with bromination of a 3.beta.,17-dihydroxy-17.alpha.-pregn-5-en-21-carboxaldehyde, leading to better yields than previously described methods.

Career Highlights

Georg Anner has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical industry. His innovative approaches and research have contributed to advancements in steroid chemistry and pharmaceutical applications.

Collaborations

Anner has collaborated with notable coworkers such as Charles Meystre and Peter Wieland. Their combined expertise has further enhanced the research and development of new pharmaceutical compounds.

Conclusion

Georg Anner's contributions to pharmaceutical chemistry through his innovative patents and collaborations have established him as a key figure in the field. His work continues to influence the development of effective medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…